The Relationship of Provider Organizational Status and Erythropoietin Dosing in End Stage Renal Disease Patients

Controversy exists as to whether provider organizational characteristics such as profit status and setting are associated with the content of medical care or efficiency with which care is rendered. Following FDA approval of human recombinant erythropoietin (EPO) for use in clinical practice, Medicare approved coverage for beneficiaries in its end stage renal disease program and established a fixed payment per dose. Because cost of EPO administration varied positively with dose, providers could realize larger profit with prescription of smaller doses. We used Medicare claims data to assess EPO use by renal dialysis providers one year after FDA approval (June 1990) as a function of provider ownership (for-profit, not-for-profit, government agency) and setting (hospital-based, free-standing). Mean dose of EPO was 236 units greater (P = 0.0001) for not-for-profit freestanding facilities, 593 units greater (P = 0.0001) for government facilities, and 555 units greater for not-for-profit hospitals (P = 0.0001) than among for-profit freestanding providers. With fixed payment per dose of EPO, for-profit, freestanding providers prescribed EPO more often and administered smaller doses than not-for-profit or government providers, behavior that is consistent with profit maximization

Business · Dosing · Erythropoietin · Medical prescription · Payment · Dialysis and Renal Disease Management · Finance · Health Systems, Economic Evaluations, Quality of Life · Healthcare Policy and Management · Internal Medicine · Medicine · Nursing

• The New Medical-Industrial Complex

  Arnold S Relman•New England Journal of Medicine•1980

  Incluir item

• Hospital Characteristics and Mortality Rates

  Arthur J Hartz, Henry Krakauer et al.•New England Journal of Medicine•1989

  Incluir item

• Ownership and performance of outpatient substance abuse treatment centers

  John R C Wheeler, J R Wheeler et al.•American Journal of Public Health•1992

  Incluir item

• Patient Selection in the Medicare End-Stage Renal Disease Program

  Gregory de Lissovoy•Medical Care•1988

  Incluir item

• The Ownership of Health Facilities and Clinical Decisionmaking

  Mark Schlesinger, Paul D Cleary et al.•Medical Care•1989

  Incluir item

• Managing Physician Incentives in Managed Care

  Mark V Pauly, Alan L Hillman et al.•Medical Care•1990

  Incluir item